Jixin Yang
No.127 Changle West Road
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Evaluation of serum tumor markers in assessing the efficacy of TP (Paclitaxel plus Carboplatin) chemotherapy combined with trastuzumab and pertuzumab dual target therapy in HER2-positive breast cancer.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: August 20, 2025
Identification and validation of prognostic genes associated with T-cell exhaustion and macrophage polarization in breast cancer.
Journal: Frontiers in endocrinology
Published: January 07, 2025
Drug treatment of breast cancer brain metastases: progress and challenges.
Journal: Discover oncology
Published: January 06, 2025
A historical controlled study of domestic trastuzumab and pertuzumab in combination with docetaxel for the neoadjuvant treatment of early HER2-positive breast cancer.
Journal: Frontiers in oncology
Published: August 22, 2023
COVID-induced 3 weeks' treatment delay may exacerbate breast cancer patient's psychological symptoms.
Journal: Frontiers in psychology
Published: July 28, 2022
Pyrotinib for HER2-positive metastatic breast cancer: a systematic review and meta-analysis.
Journal: Translational cancer research
Published: July 09, 2022
Detection and value of serum antigen KI-67 (ki67) in clinical diagnosis of breast cancer patients
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: December 16, 2020
Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 11, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026